SCHEMBL7301501

SCHEMBL7301501

CCOC(=O)C1(CI)CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
RECQL P46063 1/20 0.38
ALDH1A1 P00352 6/20 0.36
RAB9A P51151 3/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 3/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28863648 0.87 ALDH1A1 (0.39) ALDH1A1KMT2ALMNAPOLBMAPK1
SCHEMBL20564117 0.85 TSHR (0.47) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL6782433 0.84 TSHR (0.42) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL7302799 0.82 TSHR (0.41) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL1970982 0.82 TSHR (0.41) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL24242177 0.82 TSHR (0.41) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL6810064 0.82 TSHR (0.41) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL7308023 0.82 TSHR (0.41) TSHRRECQLALDH1A1RAB9AMAPT
SCHEMBL6731550 0.81 CYP3A4 (0.39) RECQLALDH1A1LMNANPSR1CYP3A4
SCHEMBL23135867 0.81 TSHR (0.43) TSHRRECQLALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed